Skip to main content
. Author manuscript; available in PMC: 2014 Oct 1.
Published in final edited form as: J Pharm Sci. 2013 Jul 29;102(10):10.1002/jps.23682. doi: 10.1002/jps.23682

Figure 2.

Figure 2

The final PK/PD model used to charactereize exenatide after two-week treatment in STZ/NA-induced diabetic rats. 0tRC·dt represents area under the drug-receptor complex concentration-time curve. fdisease(kout, t) represents the change in kout over time as a function of disease state.